Intramolecular Hydrogen-Bonded nNOS Inhibitors for BBB Penetration
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current neuronal nitric oxide synthase (nNOS) inhibitors face challenges in penetrating the blood-brain barrier due to positive charges at physiological pH, limiting their effectiveness in treating neurodegenerative diseases.
Innovation Solution
Development of small molecule compounds with improved membrane and blood-brain barrier permeability through intramolecular hydrogen bonding, allowing for selective nNOS inhibition while maintaining potency and selectivity, achieved by replacing amino groups with oxygen atoms and incorporating hydrogen bond acceptor/donor groups in the aromatic tail.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If amino groups are used in nNOS inhibitors to maintain potency and selectivity, then inhibition activity is improved, but BBB penetration is worsened due to positive charge at physiological pH
Solution Approach 1:
The patent modifies the ionization state parameter of the amino group by introducing electron-withdrawing groups (EWGs) such as pyridine, pyrimidine, or triazine rings adjacent to the amino group. This changes the pKa of the amino group, reducing its protonation at physiological pH and thereby decreasing the positive charge that blocks BBB penetration, while still maintaining nNOS inhibition activity.
Solution Approach 2:
The patent introduces an intermediary structure (the electron-withdrawing group-containing aromatic ring system) between the amino group and the rest of the molecule. This intermediary modulates the electronic properties of the amino group, reducing its positive charge density while preserving its ability to interact with the nNOS active site, thus facilitating BBB penetration without sacrificing inhibitory potency.
2Object-affected harmful factors
If amino groups are replaced by neutral functionalities to improve BBB penetration, then membrane permeability is improved, but potency and isoform selectivity are compromised
Solution Approach 1:
The patent creates a composite functional group system combining an electron-withdrawing group (such as pyridine, pyrimidine, or triazine) with an amino group in a specific spatial arrangement. This composite structure provides both the permeability benefits of a neutral/less-charged molecule and the inhibitory benefits of the amino group's interaction with nNOS, achieving a synergistic effect that resolves the contradiction between permeability and potency.
Solution Approach 2:
The patent applies local quality modification by placing electron-withdrawing groups at specific positions (adjacent to but not replacing the amino group) within the aromatic tail. This localized modification reduces the positive charge density in the critical region for BBB penetration while preserving the amino group's ability to form essential interactions with the nNOS active site, thus maintaining both permeability and potency.
3Object-affected harmful factors
If electron-withdrawing groups are incorporated next to the amino group to remove positive charge, then BBB penetration is improved, but potency and selectivity are somewhat compromised
Solution Approach 1:
The patent introduces dynamic conformational flexibility through the aromatic tail containing the electron-withdrawing group and amino group. The molecule can adopt different conformations: in the BBB penetration phase, the structure favors a conformation that minimizes positive charge exposure; in the nNOS binding phase, the structure can transition to a conformation where the amino group is positioned optimally for interaction with the enzyme active site. This dynamic adaptability resolves the contradiction between reduced charge (for penetration) and maintained potency (for inhibition).
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The compounds demonstrate enhanced lipophilicity and permeability, achieving effective nNOS inhibition with improved cellular penetration and bioavailability, as shown by in vitro and in vivo assays, while maintaining high potency and selectivity over other enzyme isoforms.
Implementation Method 1
compounds of formula (I) together with salts, hydrates and/or solvates of such compounds... capable of intramolecular hydrogen bonding
Data Source
AI summary
Compounds and related compositions and methods as can be used to selectively inhibit neuronal nitric oxide synthase and as can be employed in the treatment of various neurodegenerative diseases.